H

ere’s what we’re looking out for this week in the worlds of pharma and biotech:

Ding, ding, ding! Nasdaq’s biotech index gets a makeover

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Sign up for Morning Rounds

A daily dose of health and medicine news — and a finalist for Digiday’s best email newsletter.

Recommended Stories